{"component": "definition", "props": {"groups": [{"snippet": "means the lesser of (i) 75% of the cash price per share paid by the other purchasers of Next Round Securities in the Qualified Financing and (ii) the Conversion Price ($2.25), subject to Customary Antidilution Adjustments).", "size": 7, "snippet_links": [{"key": "lesser-of", "type": "definition", "offset": [10, 19]}, {"key": "cash-price-per-share", "type": "definition", "offset": [35, 55]}, {"key": "other-purchasers", "type": "clause", "offset": [68, 84]}, {"key": "next-round-securities", "type": "definition", "offset": [88, 109]}, {"key": "qualified-financing", "type": "clause", "offset": [117, 136]}, {"key": "conversion-price", "type": "definition", "offset": [150, 166]}, {"key": "subject-to", "type": "clause", "offset": [176, 186]}, {"key": "customary-antidilution-adjustments", "type": "definition", "offset": [187, 221]}], "samples": [{"hash": "lo6O2MSP8f6", "uri": "/contracts/lo6O2MSP8f6#automatic-conversion-price", "label": "Warrant Agreement (Marizyme Inc)", "score": 32.6269683838, "published": true}, {"hash": "7T2PsdmNUUX", "uri": "/contracts/7T2PsdmNUUX#automatic-conversion-price", "label": "Warrant Agreement (Marizyme Inc)", "score": 32.3696098328, "published": true}, {"hash": "38ANrHp2XUo", "uri": "/contracts/38ANrHp2XUo#automatic-conversion-price", "label": "Warrant Agreement (Marizyme Inc)", "score": 32.3696098328, "published": true}], "hash": "aa4076d28e21116cd8d2f9e5da472a15", "id": 1}, {"snippet": "has the meaning specified in Section 13.14(a).", "size": 6, "snippet_links": [], "samples": [{"hash": "kVhfSpnZCI8", "uri": "/contracts/kVhfSpnZCI8#automatic-conversion-price", "label": "Indenture (Oscient Pharmaceuticals Corp)", "score": 21.0, "published": true}, {"hash": "35s3PJTLtaW", "uri": "/contracts/35s3PJTLtaW#automatic-conversion-price", "label": "Indenture (Oscient Pharmaceuticals Corp)", "score": 21.0, "published": true}], "hash": "4c11139f34fc41ee4d6babc42bb6a5a0", "id": 2}, {"snippet": "shall have the meaning set forth in Section 4(d).", "size": 5, "snippet_links": [], "samples": [{"hash": "j122ikbbPc9", "uri": "/contracts/j122ikbbPc9#automatic-conversion-price", "label": "Convertible Security Agreement (Protea Biosciences Group, Inc.)", "score": 28.6577682495, "published": true}, {"hash": "4LskJg5m5rh", "uri": "/contracts/4LskJg5m5rh#automatic-conversion-price", "label": "Convertible Security Agreement (Protea Biosciences Group, Inc.)", "score": 28.3100624084, "published": true}, {"hash": "hkqW6KE0htC", "uri": "/contracts/hkqW6KE0htC#automatic-conversion-price", "label": "Convertible Security Agreement (Protea Biosciences Group, Inc.)", "score": 28.2826824188, "published": true}], "hash": "42e8bb410dbae9626ecfcacce2894c0a", "id": 3}, {"snippet": "means $0.7142 per Class A Subordinate Voting Share which is the price for which Class A Subordinate Voting Shares shall be issued upon the conversion of Series 1 Shares in accordance with Section 2.04(b) hereof, or such other dollar amount per Class A Subordinate Voting Share for which Class A Subordinate Voting Shares shall be issued upon the automatic conversion of Series 1 Shares in accordance with Article 2.05 hereof;", "size": 5, "snippet_links": [{"key": "per-class", "type": "definition", "offset": [14, 23]}, {"key": "the-price", "type": "clause", "offset": [60, 69]}, {"key": "class-a-subordinate-voting-shares", "type": "definition", "offset": [80, 113]}, {"key": "conversion-of", "type": "clause", "offset": [139, 152]}, {"key": "series-1-shares", "type": "definition", "offset": [153, 168]}, {"key": "in-accordance-with", "type": "definition", "offset": [169, 187]}, {"key": "dollar-amount", "type": "definition", "offset": [226, 239]}, {"key": "automatic-conversion", "type": "clause", "offset": [346, 366]}], "samples": [{"hash": "32hoetVcipa", "uri": "https://www.sec.gov/Archives/edgar/data/876883/000114420411025493/v220353_ex3-1.htm", "label": "MDC Partners Inc", "score": 6.3305954933, "published": false}, {"hash": "dmhgSK3Sa0F", "uri": "https://www.sec.gov/Archives/edgar/data/876883/000114420410040380/v189583_ex3-1.htm", "label": "MDC Partners Inc", "score": 5.5749487877, "published": false}, {"hash": "7J7teLxAQAH", "uri": "http://otp.investis.com/generic/sec/sec-show.aspx?FilingId=7898053&Cik=0000876883&Type=PDF", "label": "otp.investis.com", "score": 3.6652977467, "published": false}], "hash": "ce84759a451f6c6fba14352323b0ae71", "id": 4}, {"snippet": "means the \u201cConversion Price\u201d as defined in each Note.", "size": 4, "snippet_links": [{"key": "conversion-price", "type": "definition", "offset": [11, 27]}], "samples": [{"hash": "is0dBvkmlrf", "uri": "/contracts/is0dBvkmlrf#automatic-conversion-price", "label": "Warrant Agreement (Marizyme, Inc.)", "score": 33.7549629211, "published": true}, {"hash": "bkRg1IEEOkG", "uri": "/contracts/bkRg1IEEOkG#automatic-conversion-price", "label": "Warrant Agreement (Marizyme, Inc.)", "score": 33.7549629211, "published": true}, {"hash": "CVKUnSZ7XC", "uri": "/contracts/CVKUnSZ7XC#automatic-conversion-price", "label": "Warrant Agreement (Marizyme, Inc.)", "score": 33.577003479, "published": true}], "hash": "60889ebb5776280294681c2ce6fd2ae0", "id": 5}, {"snippet": "means the lesser of (i) 75% of the cash price per share paid by the other purchasers of Next Round Securities in the Qualified Financing and (ii) the Conversion Price ($0.10), subject to Customary Antidilution Adjustments).", "size": 4, "snippet_links": [{"key": "lesser-of", "type": "definition", "offset": [10, 19]}, {"key": "cash-price-per-share", "type": "definition", "offset": [35, 55]}, {"key": "other-purchasers", "type": "clause", "offset": [68, 84]}, {"key": "next-round-securities", "type": "definition", "offset": [88, 109]}, {"key": "qualified-financing", "type": "clause", "offset": [117, 136]}, {"key": "conversion-price", "type": "definition", "offset": [150, 166]}, {"key": "subject-to", "type": "clause", "offset": [176, 186]}, {"key": "customary-antidilution-adjustments", "type": "definition", "offset": [187, 221]}], "samples": [{"hash": "iLgWMjwklxP", "uri": "/contracts/iLgWMjwklxP#automatic-conversion-price", "label": "Warrant Agreement (Marizyme, Inc.)", "score": 33.577003479, "published": true}, {"hash": "fHNqR9cDwhA", "uri": "/contracts/fHNqR9cDwhA#automatic-conversion-price", "label": "Warrant Agreement (Marizyme, Inc.)", "score": 33.577003479, "published": true}, {"hash": "aZPn0I8Ywk5", "uri": "https://d18rn0p25nwr6d.cloudfront.net/CIK-0001413754/59b996ec-5aec-430c-955e-6ae17aca431d.pdf", "label": "d18rn0p25nwr6d.cloudfront.net", "score": 12.0417518616, "published": false}], "hash": "9173218a6738a0d374f0593404e68c3d", "id": 6}, {"snippet": "means: In the case of an IPO or a Sale (A) if the IPO occurs or a Sale is completed on or after 1 January 2021, the Automatic Conversion Price shall be the Conversion Price calculated in accordance with Condition 3.6 of this Schedule 2. For example, if more than 20,000 LumiraDx Instruments have been Sold by 11.59 p.m. (UK time) on 31 December 2020 then the Conversion Price at the Automatic Conversion Date shall be the 20,000 Conversion Price; or (B) if the IPO occurs or a Sale is completed prior to 1 January 2021 then the Automatic Conversion Price shall be the Conversion Price calculated in accordance with Condition 3.6 of this Schedule 2 but on the basis of the number of LumiraDx Instruments Sold as at the end of the calendar month immediately preceding the IPO or the Sale completing (as applicable) with the minimum Automatic Conversion Price being, in all circumstances, the 12,000 Conversion Price. For example, if the IPO occurred or a Sale is completed on 15 December 2020, then the Conversion Price would be calculated on the basis of the number of LumiraDx Instruments Sold as at 30 November 2020. So if the number of LumiraDx Instruments Sold at such date was 11,000 then applying the provisions of Condition 3.6 of this Schedule 2 the Conversion Price would be the 12,000 Conversion Price.", "size": 3, "snippet_links": [{"key": "in-the-case-of-an", "type": "clause", "offset": [7, 24]}, {"key": "the-ipo", "type": "clause", "offset": [46, 53]}, {"key": "the-conversion", "type": "clause", "offset": [152, 166]}, {"key": "in-accordance-with", "type": "definition", "offset": [184, 202]}, {"key": "schedule-2", "type": "definition", "offset": [225, 235]}, {"key": "for-example", "type": "definition", "offset": [237, 248]}, {"key": "uk-time", "type": "definition", "offset": [321, 328]}, {"key": "december-2020", "type": "clause", "offset": [336, 349]}, {"key": "automatic-conversion-date", "type": "definition", "offset": [383, 408]}, {"key": "prior-to", "type": "definition", "offset": [495, 503]}, {"key": "basis-of", "type": "clause", "offset": [659, 667]}, {"key": "number-of", "type": "clause", "offset": [672, 681]}, {"key": "at-the-end-of-the", "type": "clause", "offset": [711, 728]}, {"key": "calendar-month", "type": "clause", "offset": [729, 743]}, {"key": "the-sale", "type": "clause", "offset": [777, 785]}, {"key": "november-2020", "type": "clause", "offset": [1103, 1116]}, {"key": "the-provisions-of", "type": "clause", "offset": [1202, 1219]}], "samples": [{"hash": "cvhAHJfVkaA", "uri": "/contracts/cvhAHJfVkaA#automatic-conversion-price", "label": "Convertible Loan Instrument (LumiraDx LTD)", "score": 32.5126609802, "published": true}, {"hash": "5wFYmBMUbNk", "uri": "/contracts/5wFYmBMUbNk#automatic-conversion-price", "label": "Convertible Loan Instrument (LumiraDx LTD)", "score": 32.0390129089, "published": true}, {"hash": "8lSgCSKy6Cy", "uri": "/contracts/8lSgCSKy6Cy#automatic-conversion-price", "label": "Convertible Loan Instrument (LumiraDx LTD)", "score": 31.9760437012, "published": true}], "hash": "3c1101f28fe5580b3150c2b521e9819d", "id": 7}, {"snippet": "means, with respect to a particular date of determination, the lower of (i) the Conversion Price then in effect and (ii) the price which is equal to the product of (1) 70% multiplied by (2) the quotient of (A) the sum of each of the three (3) lowest Closing Bid Prices of the Common Stock during the twenty (20) consecutive Trading Day period immediately preceding the applicable Installment Date (or, solely with respect to the First Installment Date, the sum of each of the three (3) lowest Closing Bid Prices of the Common Stock during the period commencing on the Issuance Date and ending on the Trading Day immediately preceding the First Installment Date) (each such period, an \u201cAutomatic Conversion Measuring Period\u201d) divided by (B) three (3). All such determinations to be appropriately adjusted for any stock split, stock dividend, stock combination or other similar transaction during any such Automatic Conversion Measuring Period. In the event of a dispute as to the determination of the Automatic Conversion Price, then such dispute shall be resolved pursuant to Section 21.", "size": 3, "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "date-of-determination", "type": "definition", "offset": [36, 57]}, {"key": "the-conversion", "type": "clause", "offset": [76, 90]}, {"key": "in-effect", "type": "clause", "offset": [102, 111]}, {"key": "the-price", "type": "clause", "offset": [121, 130]}, {"key": "equal-to", "type": "definition", "offset": [140, 148]}, {"key": "the-product", "type": "clause", "offset": [149, 160]}, {"key": "sum-of", "type": "clause", "offset": [214, 220]}, {"key": "closing-bid-prices", "type": "definition", "offset": [250, 268]}, {"key": "the-common-stock", "type": "clause", "offset": [272, 288]}, {"key": "trading-day-period", "type": "definition", "offset": [324, 342]}, {"key": "the-applicable", "type": "clause", "offset": [365, 379]}, {"key": "first-installment-date", "type": "definition", "offset": [429, 451]}, {"key": "during-the-period", "type": "clause", "offset": [532, 549]}, {"key": "issuance-date", "type": "clause", "offset": [568, 581]}, {"key": "measuring-period", "type": "definition", "offset": [706, 722]}, {"key": "divided-by", "type": "clause", "offset": [725, 735]}, {"key": "stock-split", "type": "clause", "offset": [812, 823]}, {"key": "stock-dividend", "type": "definition", "offset": [825, 839]}, {"key": "stock-combination", "type": "definition", "offset": [841, 858]}, {"key": "similar-transaction", "type": "definition", "offset": [868, 887]}, {"key": "in-the-event-of-a-dispute", "type": "clause", "offset": [943, 968]}, {"key": "determination-of-the", "type": "clause", "offset": [979, 999]}, {"key": "section-21", "type": "definition", "offset": [1076, 1086]}], "samples": [{"hash": "6K7SuA1xuN0", "uri": "https://www.sec.gov/Archives/edgar/data/838879/000114420411043372/v230560_ex10-1.htm", "label": "RADIENT PHARMACEUTICALS Corp", "score": 6.5824775696, "published": false}], "hash": "dc4a0f18e8c3a16c23ed625f529002f7", "id": 8}, {"snippet": "means, with respect to the applicable date of determination, the lower of (i) the Conversion Price then in effect and (ii) the price which is equal to the product of (1) 85% multiplied by (2) the quotient of (A) the sum of each of the three (3) lowest Closing Bid Prices of the Common Stock during the twenty (20) consecutive Trading Day period immediately preceding the applicable Automatic Conversion Date (each such period, a \u201cAutomatic Conversion Measuring Period\u201d) divided by (B) three (3). All such determinations to be appropriately adjusted for any stock split, stock dividend, stock combination or other similar transaction during any such Automatic Conversion Measuring Period.", "size": 2, "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "applicable-date-of-determination", "type": "definition", "offset": [27, 59]}, {"key": "conversion-price", "type": "definition", "offset": [82, 98]}, {"key": "in-effect", "type": "clause", "offset": [104, 113]}, {"key": "the-price", "type": "clause", "offset": [123, 132]}, {"key": "equal-to", "type": "definition", "offset": [142, 150]}, {"key": "the-product", "type": "clause", "offset": [151, 162]}, {"key": "sum-of", "type": "clause", "offset": [216, 222]}, {"key": "closing-bid-prices", "type": "definition", "offset": [252, 270]}, {"key": "the-common-stock", "type": "clause", "offset": [274, 290]}, {"key": "trading-day-period", "type": "definition", "offset": [326, 344]}, {"key": "automatic-conversion-date", "type": "definition", "offset": [382, 407]}, {"key": "measuring-period", "type": "definition", "offset": [451, 467]}, {"key": "divided-by", "type": "clause", "offset": [470, 480]}, {"key": "stock-split", "type": "clause", "offset": [557, 568]}, {"key": "stock-dividend", "type": "definition", "offset": [570, 584]}, {"key": "stock-combination", "type": "definition", "offset": [586, 603]}, {"key": "similar-transaction", "type": "definition", "offset": [613, 632]}], "samples": [{"hash": "1flAsZU3Jpg", "uri": "https://www.sec.gov/Archives/edgar/data/1043873/000093041311001082/c64389_ex3-1.htm", "label": "Novadel Pharma Inc", "score": 6.1225190163, "published": false}, {"hash": "cAeNkMRkZTa", "uri": "https://www.sec.gov/Archives/edgar/data/1043873/000093041311000879/c63032_ex3-4.htm", "label": "Novadel Pharma Inc", "score": 6.1088294983, "published": false}], "hash": "ac14cd6807675834f92e141ce4796455", "id": 9}, {"snippet": "has the meaning provided in Section 5.04(e).", "size": 2, "snippet_links": [], "samples": [{"hash": "l7sEjk5mbcX", "uri": "/contracts/l7sEjk5mbcX#automatic-conversion-price", "label": "Series a Preferred Share Subscription Agreement (GDS Holdings LTD)", "score": 35.2368240356, "published": true}], "hash": "bdccba765860765cafe7749d57d379b3", "id": 10}], "next_curs": "CmcSYWoVc35sYXdpbnNpZGVyY29udHJhY3RzckMLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIjYXV0b21hdGljLWNvbnZlcnNpb24tcHJpY2UjMDAwMDAwMGEMogECZW4YACAA", "definition": {"snippet": "means the lesser of (i) 75% of the cash price per share paid by the other purchasers of Next Round Securities in the Qualified Financing and (ii) the Conversion Price ($2.25), subject to Customary Antidilution Adjustments).", "size": 53, "title": "Automatic Conversion Price", "id": "automatic-conversion-price", "examples": [], "related": [["new-conversion-price", "New Conversion Price", "New Conversion Price"], ["company-conversion-price", "Company Conversion Price", "Company Conversion Price"], ["series-a-conversion-price", "Series A Conversion Price", "Series A Conversion Price"], ["automatic-conversion", "Automatic Conversion", "Automatic Conversion"], ["series-b-conversion-price", "Series B Conversion Price", "Series B Conversion Price"]], "related_snippets": [], "updated": "2025-12-04T05:48:23+00:00"}, "json": true, "cursor": ""}}